Teleflex Incorporated Stock

Equities

TFX

US8793691069

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe BZX 11:53:50 2024-04-22 am EDT 5-day change 1st Jan Change
208 USD +0.68% Intraday chart for Teleflex Incorporated -1.49% -16.77%
Sales 2024 * 3.09B Sales 2025 * 3.27B Capitalization 9.73B
Net income 2024 * 365M Net income 2025 * 501M EV / Sales 2024 * 3.32 x
Net Debt 2024 * 534M Net cash position 2025 * 34M EV / Sales 2025 * 2.97 x
P/E ratio 2024 *
27.2 x
P/E ratio 2025 *
19.8 x
Employees 14,500
Yield 2024 *
0.66%
Yield 2025 *
0.67%
Free-Float 97.66%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.40%
1 week-3.67%
Current month-8.67%
1 month-7.95%
3 months-16.31%
6 months+10.13%
Current year-17.16%
More quotes
1 week
205.26
Extreme 205.26
213.23
1 month
205.26
Extreme 205.26
227.65
Current year
205.26
Extreme 205.26
256.85
1 year
177.63
Extreme 177.633
276.43
3 years
177.63
Extreme 177.633
449.38
5 years
177.63
Extreme 177.633
449.38
10 years
99.56
Extreme 99.56
449.38
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 08-12-31
Director of Finance/CFO 62 11-07-31
Compliance Officer - 17-12-31
Members of the board TitleAgeSince
Director/Board Member 69 17-12-31
Director/Board Member 64 08-12-31
Director/Board Member 69 18-12-31
More insiders
Date Price Change Volume
24-04-22 207.5 +0.44% 67 395
24-04-19 206.6 -0.40% 416,411
24-04-18 207.4 -0.44% 154,319
24-04-17 208.3 -0.86% 170,359
24-04-16 210.1 -0.27% 202,561

Delayed Quote Nyse, April 19, 2024 at 04:00 pm EDT

More quotes
Teleflex Incorporated specialises in the designing, manufacturing and selling of single-use medical devices for hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. Products are sold under the brand names Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rusch® and Weck®. Net sales break down by category of products as follows: - interventional cardiology, radiology and urology products (26.5%); - vascular access solutions (25.9%); - surgical devices (12.5%); - anesthesia products (11.9%); - other (23.2%). Net sales are distributed geographically as follows: the United States (61.8%), Europe (25.5%), Asia-Pacific (9.1%) and other (3.6%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
206.6 USD
Average target price
262.4 USD
Spread / Average Target
+27.04%
Consensus